201 related articles for article (PubMed ID: 3142286)
41. Factors affecting infection or reinfection with Schistosoma haematobium in coastal Kenya: survival analysis during a nine-year, school-based treatment program.
Satayathum SA; Muchiri EM; Ouma JH; Whalen CC; King CH
Am J Trop Med Hyg; 2006 Jul; 75(1):83-92. PubMed ID: 16837713
[TBL] [Abstract][Full Text] [Related]
42. Long-term outcomes of school-based treatment for control of urinary schistosomiasis: a review of experience in Coast Province, Kenya.
King CH
Mem Inst Oswaldo Cruz; 2006 Sep; 101 Suppl 1():299-306. PubMed ID: 17308786
[TBL] [Abstract][Full Text] [Related]
43. Schistosoma haematobium: a neglected common parasitic disease of childhood in Nigeria. Incidence and intensity of infection.
Bello AB; Edungbola LD
Acta Paediatr; 1992 Aug; 81(8):601-4. PubMed ID: 1392384
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of an ultrasonographic score for urinary bladder morbidity in Schistosoma haematobium infection.
Medhat A; Zarzour A; Nafeh M; Shata T; Sweifie Y; Attia M; Helmy A; Shehata M; Zaki S; Mikhail N; Ibrahim S; King C; Strickland GT
Am J Trop Med Hyg; 1997 Jul; 57(1):16-9. PubMed ID: 9242311
[TBL] [Abstract][Full Text] [Related]
45. Protocol and baseline data for a multi-year cohort study of the effects of different mass drug treatment approaches on functional morbidities from schistosomiasis in four African countries.
Shen Y; King CH; Binder S; Zhang F; Whalen CC; Evan Secor W; Montgomery SP; Mwinzi PNM; Olsen A; Magnussen P; Kinung'hi S; Phillips AE; Nalá R; Ferro J; Aurelio HO; Fleming F; Garba A; Hamidou A; Fenwick A; Campbell CH; Colley DG
BMC Infect Dis; 2017 Sep; 17(1):652. PubMed ID: 28962552
[TBL] [Abstract][Full Text] [Related]
46. Urinary schistosomiasis in France.
Douard A; Cornelis F; Malvy D
Int J Infect Dis; 2011 Jul; 15(7):e506-7. PubMed ID: 21524931
[No Abstract] [Full Text] [Related]
47. The pathobiology of Schistosoma haematobium infection in humans.
Smith JH; Christie JD
Hum Pathol; 1986 Apr; 17(4):333-45. PubMed ID: 3082740
[TBL] [Abstract][Full Text] [Related]
48. Dose-finding study for praziquantel therapy of Schistosoma haematobium in Coast Province, Kenya.
King CH; Wiper DW; De Stigter KV; Peters PA; Koech D; Ouma JH; Arap Siongok TK; Mahmoud AA
Am J Trop Med Hyg; 1989 May; 40(5):507-13. PubMed ID: 2499203
[TBL] [Abstract][Full Text] [Related]
49. Ultrasonographical aspects of urinary schistosomiasis: assessment of morphological lesions in the upper and lower urinary tract.
Dittrich M; Doehring E
Pediatr Radiol; 1986; 16(3):225-30. PubMed ID: 3085056
[TBL] [Abstract][Full Text] [Related]
50. Factors associated with urinary schistosomiasis in two peri-urban communities in south-western Nigeria.
Ugbomoiko US; Ofoezie IE; Okoye IC; Heukelbach J
Ann Trop Med Parasitol; 2010 Jul; 104(5):409-19. PubMed ID: 20819309
[TBL] [Abstract][Full Text] [Related]
51. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal.
Meurs L; Mbow M; Vereecken K; Menten J; Mboup S; Polman K
Int J Parasitol; 2012; 42(3):305-11. PubMed ID: 22366733
[TBL] [Abstract][Full Text] [Related]
52. Efficacy of metrifonate in a highly endemic area of urinary schistosomiasis in Kenya.
Sato K; Shimada M; Noda S; Muhoho ND; Katsumata T; Sato A; Aoki Y
Am J Trop Med Hyg; 1988 Jan; 38(1):81-5. PubMed ID: 3124647
[TBL] [Abstract][Full Text] [Related]
53. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya.
Kahama AI; Odek AE; Kihara RW; Vennervald BJ; Kombe Y; Nkulila T; Hatz CF; Ouma JH; Deelder AM
Am J Trop Med Hyg; 1999 Aug; 61(2):215-9. PubMed ID: 10463669
[TBL] [Abstract][Full Text] [Related]
54. Urinary disease in 2 Dogon populations with different exposure to Schistosoma haematobium infection: progression of bladder and kidney diseases in children and adults.
Kouriba B; Traore HA; Dabo A; Sangare L; Guindo H; Keita AS; Reimert CM; van Dam GJ; Deelder AM; Doumbo O; Dessein AJ
J Infect Dis; 2005 Dec; 192(12):2152-9. PubMed ID: 16288382
[TBL] [Abstract][Full Text] [Related]
55. Schistosoma haematobium-induced urinary tract morbidity correlates with increased tumor necrosis factor-alpha and diminished interleukin-10 production.
King CL; Malhotra I; Mungai P; Wamachi A; Kioko J; Muchiri E; Ouma JH
J Infect Dis; 2001 Nov; 184(9):1176-82. PubMed ID: 11598841
[TBL] [Abstract][Full Text] [Related]
56. Ultrasound for detecting Schistosoma haematobium urinary tract complications: comparison with radiographic procedures.
Abdel-Wahab MF; Ramzy I; Esmat G; el Kafass H; Strickland GT
J Urol; 1992 Aug; 148(2 Pt 1):346-50. PubMed ID: 1635130
[TBL] [Abstract][Full Text] [Related]
57. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya.
King CH; Muchiri E; Ouma JH; Koech D
Am J Trop Med Hyg; 1991 Oct; 45(4):498-508. PubMed ID: 1951859
[TBL] [Abstract][Full Text] [Related]
58. The epidemiology of schistosomiasis in Egypt: Gharbia Governorate.
El-Hawey AM; Amr MM; Abdel-Rahman AH; El-Ibiary SA; Agina AM; Abdel-Hafez MA; Waheeb AA; Hussein MH; Strickland GT
Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):42-8. PubMed ID: 10813499
[TBL] [Abstract][Full Text] [Related]
59. A comparative study on the efficacy of praziquantel and albendazole in the treatment of urinary schistosomiasis in Adim, Cross River State, Nigeria.
Ben SA; Useh MF
Int Health; 2017 Sep; 9(5):288-293. PubMed ID: 28911129
[TBL] [Abstract][Full Text] [Related]
60. Case Report of Urinary Schistosomiasis in a Returned Traveler in Korea.
Lee Y; Song HB; Jung BK; Choe G; Choi MH
Korean J Parasitol; 2020 Feb; 58(1):51-55. PubMed ID: 32145727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
